Oxytocin
Brand Names: Pitocin
Methodology & AI Transparency ⓘ
Oxytocin Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Indications and usage important notice:: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor.
- 2 Real-world patient consensus: 83% patient "Worth It" rating across 18 anonymous logs for Oxytocin (RxNorm 238013).
- 3 Typical cash cost range: Public pharmacy ledger: $143.77 low cash benchmark vs. $352.24 chain retail average ($3.3400/unit CMS NADAC).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Oxytocin include nausea (10.2%), vomiting (3.8%), headache (6.5%).
Ask our AI Specialists anything about Oxytocin
Oxytocin Mechanism, CYP450 Pathways & DailyMed Monograph
Indications and usage important notice:: Oxytocin Injection, USP (synthetic) is indicated for the medical rather than the elective induction of labor. Available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction. Elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications.
CLINICAL PHARMACOLOGY Oxytocin injection (synthetic) acts on the smooth muscle of the uterus to stimulate contractions; response depends on the uterine threshold of excitability. It exerts a selective action on the smooth musculature of the uterus, particularly toward the end of pregnancy, during labor and immediately following delivery. Oxytocin stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions and raises the tone of the uterine musculature.
Following administration (10 [USP'U]/mL Injection, Solution), Oxytocin achieves Complete (~100%) parenteral systemic delivery for Oxytocin (10 [USP'U]/mL Injection, Solution) bioavailability and rapid intravascular/parenteral onset within 15–45 minutes after oxytocin administration onset, governed by a Approximately 6–18 hours terminal plasma half-life for Oxytocin terminal half-life through phase i/ii hepatic conjugation of oxytocin coupled with glomerular and tubular renal excretion.
Before initiating Oxytocin at 10 [USP'U]/mL Injection, Solution, clinical safety checklists rule out contraindications oxytocin injection (synthetic) is contraindicated in any of the following conditions:; significant cephalopelvic disproportion; unfavorable fetal positions or presentations which are undeliverable without conversion prior to delivery, i.e., transverse lies. Logged tolerability patterns center on nausea (10.2% of reports), headache (6.5% of reports), dizziness (5.9% of reports).
Avoid overlapping oxytocic prescriptions alongside Oxytocin to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Oxytocin; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Oxytocin injection (synthetic) is contraindicated in any of the following conditions:
- Significant cephalopelvic disproportion
- Unfavorable fetal positions or presentations which are undeliverable without conversion prior to delivery, i.e., transverse lies
Logged Side-Effect Incidence (18 Reports)
Oxytocin Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Oxytocin)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Misoprostol with and without methylergometrine and oxytocin in outpatient medical The effectiveness of the drugs in the two drug groups combined with oxytocin and methylergometrine is higher than the misoprostol group alone. BMC research notes • 2023-10-05 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 37798748 ↗ |
Oxytocin Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $3.3400/unit (~$100.20/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $352.24 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $143.77 / mo | View logs ↓ |
Oxytocin Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Oxytocin RxNorm Concept ID | 238013 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $3.3400 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $352.24 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $143.77 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 83.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Oxytocin Patient Community, Cohort Filters & Dosage Logs
Evidence synthesis for Oxytocin: FDA labeling (2024-10-15, NDC 63323-012), CYP/interaction screening, and public pharmacy acquisition costs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Oxytocin community threads and patient logs by age, biological sex, dosage, and treatment duration.